Mark L. Chapman

3.5k total citations
56 papers, 1.7k citations indexed

About

Mark L. Chapman is a scholar working on Molecular Biology, Surgery and Orthopedics and Sports Medicine. According to data from OpenAlex, Mark L. Chapman has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Surgery and 13 papers in Orthopedics and Sports Medicine. Recurrent topics in Mark L. Chapman's work include Ion channel regulation and function (15 papers), Sports Performance and Training (9 papers) and Inflammatory Bowel Disease (9 papers). Mark L. Chapman is often cited by papers focused on Ion channel regulation and function (15 papers), Sports Performance and Training (9 papers) and Inflammatory Bowel Disease (9 papers). Mark L. Chapman collaborates with scholars based in United States, United Kingdom and Spain. Mark L. Chapman's co-authors include Daniel H. Present, Carol Bodian, Antonius M.J. VanDongen, Peter Rubin, James F. Marion, Brian E. Marron, Hendrika M.A. VanDongen, Nigel A. Swain, Noam Harpaz and Ellen Scherl and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and The Journal of Physiology.

In The Last Decade

Mark L. Chapman

53 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark L. Chapman United States 22 571 481 400 337 312 56 1.7k
Robert D. Bart United States 25 540 0.9× 174 0.4× 255 0.6× 211 0.6× 487 1.6× 45 2.3k
Leslie A. Lange United States 24 538 0.9× 355 0.7× 270 0.7× 251 0.7× 216 0.7× 65 2.0k
Michael Pike United Kingdom 24 459 0.8× 385 0.8× 141 0.4× 186 0.6× 246 0.8× 61 1.9k
Andrew P. Feranchak United States 33 929 1.6× 222 0.5× 608 1.5× 196 0.6× 243 0.8× 53 2.8k
Gábor Horváth Hungary 23 281 0.5× 150 0.3× 292 0.7× 129 0.4× 264 0.8× 125 1.6k
Albert Y. Wu United States 21 620 1.1× 127 0.3× 211 0.5× 225 0.7× 221 0.7× 84 1.5k
Keita Harada Japan 22 425 0.7× 400 0.8× 565 1.4× 161 0.5× 311 1.0× 139 1.9k
Wayne V. Moore United States 30 923 1.6× 908 1.9× 600 1.5× 91 0.3× 101 0.3× 88 2.6k
Shigehiko Kamoshita Japan 22 837 1.5× 190 0.4× 178 0.4× 156 0.5× 262 0.8× 103 2.1k
Naoyuki Miyasaka Japan 26 365 0.6× 124 0.3× 193 0.5× 73 0.2× 211 0.7× 137 2.3k

Countries citing papers authored by Mark L. Chapman

Since Specialization
Citations

This map shows the geographic impact of Mark L. Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Chapman more than expected).

Fields of papers citing papers by Mark L. Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Chapman. The network helps show where Mark L. Chapman may publish in the future.

Co-authorship network of co-authors of Mark L. Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Chapman. A scholar is included among the top collaborators of Mark L. Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Chapman. Mark L. Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poslusney, Michael S., et al.. (2024). Development and characterization of pyridyl carboxamides as potent and highly selective Nav1.8 inhibitors. Bioorganic & Medicinal Chemistry Letters. 117. 130059–130059. 1 indexed citations
2.
Pryde, David C., Nigel A. Swain, Paul A. Stupple, et al.. (2017). The discovery of a potent Nav1.3 inhibitor with good oral pharmacokinetics. MedChemComm. 8(6). 1255–1267. 6 indexed citations
3.
Theile, Jonathan W., Matthew D. Fuller, & Mark L. Chapman. (2016). The Selective Nav1.7 Inhibitor, PF-05089771, Interacts Equivalently with Fast and Slow Inactivated Nav1.7 Channels. Molecular Pharmacology. 90(5). 540–548. 35 indexed citations
4.
Theile, Jonathan W., Matthew D. Fuller, & Mark L. Chapman. (2015). Nav1.7 Inhibitor, PF-05089771, Inhibits Fast- and Slow-Inactivated Channels with Similar Affinities. Biophysical Journal. 108(2). 573a–574a. 1 indexed citations
5.
Marion, James F., Jerome D. Waye, Yuriy Israel, et al.. (2015). Chromoendoscopy Is More Effective Than Standard Colonoscopy in Detecting Dysplasia During Long-term Surveillance of Patients With Colitis. Clinical Gastroenterology and Hepatology. 14(5). 713–719. 43 indexed citations
6.
Bagal, Sharan K., et al.. (2014). Recent progress in sodium channel modulators for pain. Bioorganic & Medicinal Chemistry Letters. 24(16). 3690–3699. 124 indexed citations
7.
Allgrove, Judith, et al.. (2012). Immunoendocrine responses of male spinal cord injured athletes to 1-hour self-paced exercise: Pilot study. The Journal of Rehabilitation Research and Development. 49(6). 925–925. 6 indexed citations
8.
Iglesias‐Soler, Eliseo, et al.. (2012). Acute Effects of Distribution of Rest between Repetitions. International Journal of Sports Medicine. 33(5). 351–358. 50 indexed citations
9.
Zhang, Xu‐Feng, Char‐Chang Shieh, Mark L. Chapman, et al.. (2010). A-887826 is a structurally novel, potent and voltage-dependent Nav1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats. Neuropharmacology. 59(3). 201–207. 44 indexed citations
10.
Scanio, Marc J. C., Lei Shi, Irene Drizin, et al.. (2010). Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Nav1.8 sodium channel with efficacy in a model of neuropathic pain. Bioorganic & Medicinal Chemistry. 18(22). 7816–7825. 27 indexed citations
11.
Marion, James F., Jerome D. Waye, Daniel H. Present, et al.. (2008). Chromoendoscopy-Targeted Biopsies Are Superior to Standard Colonoscopic Surveillance for Detecting Dysplasia in Inflammatory Bowel Disease Patients: A Prospective Endoscopic Trial. The American Journal of Gastroenterology. 103(9). 2342–2349. 215 indexed citations
12.
Nilubol, Naris, Ellen Scherl, Stephen R. Gorfine, et al.. (2007). Mucosal Dysplasia in Ileal Pelvic Pouches After Restorative Proctocolectomy. Diseases of the Colon & Rectum. 50(6). 825–831. 30 indexed citations
13.
Krafte, Douglas S., Mark L. Chapman, Brian E. Marron, et al.. (2007). Block of Nav1.8 by Small Molecules. Channels. 1(3). 152–153. 4 indexed citations
14.
Chapman, Mark L., et al.. (2005). Allosteric effects of external K+ ions mediated by the aspartate of the GYGD signature sequence in the Kv2.1 K+ channel. Pflügers Archiv - European Journal of Physiology. 451(6). 776–792. 8 indexed citations
15.
Goss‐Sampson, Mark & Mark L. Chapman. (2003). Temporal and kinematic analysis of the rotational shot put technique. Journal of Sports Sciences. 1 indexed citations
16.
Bodian, Carol, et al.. (2003). The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: A retrospective cohort study. Gastroenterology. 124(1). 9–17. 217 indexed citations
17.
Chapman, Mark L., et al.. (2001). GYGD pore motifs in neighbouring potassium channel subunits interact to determine ion selectivity. The Journal of Physiology. 530(1). 21–33. 39 indexed citations
18.
Chapman, Mark L., Hendrika M.A. VanDongen, & Antonius M.J. VanDongen. (1997). Activation-Dependent Subconductance Levels in the drk1 K Channel Suggest a Subunit Basis for Ion Permeation and Gating. Biophysical Journal. 72(2). 708–719. 104 indexed citations
19.
Present, Daniel H., et al.. (1988). Medical Decompression of Toxic Megacolon by ???Rolling???. Journal of Clinical Gastroenterology. 10(5). 485–490. 31 indexed citations
20.
Chapman, Mark L.. (1978). Peptic Ulcer: A Medical Perspective. Medical Clinics of North America. 62(1). 39–51. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert D. Bart Breakdown of academic impact, for papers by Leslie A. Lange Breakdown of academic impact, for papers by Michael Pike Breakdown of academic impact, for papers by Andrew P. Feranchak Breakdown of academic impact, for papers by Gábor Horváth Breakdown of academic impact, for papers by Albert Y. Wu Breakdown of academic impact, for papers by Keita Harada Breakdown of academic impact, for papers by Wayne V. Moore Breakdown of academic impact, for papers by Shigehiko Kamoshita Breakdown of academic impact, for papers by Naoyuki Miyasaka
Rankless by CCL
2026